Company overview
Anhui Zhifei Longcom Biopharmaceutical Co., Ltd.
USCC
91340100726322279A
Id2
340000000000889
English Name
Anhui Zhifei Longcom Biopharmaceutical Co., Ltd.
Former names
安徽龙科马生物制药有限责任公司
Chinese Name
安徽智飞龙科马生物制药有限公司
Entity type
Limited Liability Company (Sole Legal-Person Ownership, Non-Natural Person)
Authorized capital
¥76,500
vaccae@zhifeishengwu.com
Phone
+8655165315667
Representative
李万军 (Li Wan Jun)
Establishment date
5 January 2001
Country
China
Primary goods traded
- 💉93.3% — Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products (300241)
- 3.4% — 300220 (300220)
- 💊3.4% — Medicaments (300490)
Main Trading Partners
| Partner | Type | Total Value | Percentage |
|---|---|---|---|
| PT Jakarta Biopharmaceutical Industry | buyer | $1,000,000 | 93.27% |
| PT Bcht Bioteknologi Indonesia | buyer | $72,137 | 6.73% |
Loading chart...
Loading chart...
Loading chart...
Loading chart...
Trade Data
| Data Source | HS Code | Description | Buyer | Buyer Country | Seller | Seller Country | ||
|---|---|---|---|---|---|---|---|---|
| 31 October 2022 | ID | 30024190 | Zifivax (Recombinant Protein Ncprbd Of Sars-Cov-2 Virus, Injection, Box 1 Vial @0.5Ml | PT Jakarta Biopharmaceutical Industry | ID | Anhui Zhifei Longcom Biopharmaceutical Company Limited | CN | $1,000,000.00 |
| 19 February 2021 | ID | 30049099 | Recombinant Novel Coronavirus Vaccine Placebo Baik & Baru | PT Bcht Bioteknologi Indonesia | ID | Anhui Zhifei Longcom Biopharma | CN | $36,068.40 |
| 19 February 2021 | ID | 30022090 | Recombinant Novel Coronavirus Vaccine (Cho Cell) Baik & Baru | PT Bcht Bioteknologi Indonesia | ID | Anhui Zhifei Longcom Biopharma | CN | $36,068.40 |
0 of 3 row(s) selected.